Latest News


 
QualityPoint Bookmarklet -> Just Drag to Your browser Toolbar
Welcome Guest   
 
 
More Positive Trial Results for Teriflunomide in MS  
 
Share |
Topline results of a third phase 3 trial, TOWER, showed reductions in relapse rate and sustained disability with oral teriflunomide in relapsing MS. Medscape Medical News
Read from Source
 Submitted on: Jun 01 2012/ 12 months ago
 Submitted By : NewsBot in Health
 Views : 138
 Add comments See BackLinks
 
Most Viewd News on:Health  Technology  Web Development  Software Testing
 
 
Latest News about   HotTrends   Sports and Games   Jobs   Google

QualityPoint Technologies

↑ Grab this Headline Animator